Hanheal Exosome Rejuvenating
Premium human-derived exosome for skin hydration, texture, radiance, and elasticity support in clinical protocols.
Professional-grade human-derived exosome skin booster for intensive hydration, visible plumpness, and overall skin quality enhancement. Designed for intradermal injection protocols in clinical aesthetic settings, with a concentrated exosome payload to support comprehensive skin rejuvenation.
The Exosome Skin Booster is a concentrated human-derived exosome preparation specifically formulated for the professional skin booster category. This product class — well-established in Korean aesthetic medicine — delivers active compounds intradermally to support localised skin quality, hydration, and overall complexion improvement.
Unlike topical exosome products, the Skin Booster is designed for intradermal delivery — injectable via fine-needle mesotherapy or skin booster device — which enables the exosome payload to reach the dermis where its biological activity is most relevant to skin structure and appearance.
The product's human-derived exosome base carries a growth factor profile — including signalling peptides relevant to hydration, extracellular matrix, and skin cell communication — consistent with published research on extracellular vesicles in skin biology. All clinical claims remain within the bounds of supportive, non-therapeutic language.
Regulatory Notice: The Exosome Skin Booster is a professional aesthetic product. It is not a drug and has not received FDA, EMA, or equivalent pharmaceutical approval. For professional use only by trained practitioners. Evidence supporting exosome skin booster applications is emerging and preliminary.
Formulated for intradermal delivery via mesotherapy injection or skin booster device, enabling direct dermal delivery of the exosome payload.
High-concentration formulation designed to support visible skin hydration, moisture retention, and the plumpness associated with well-hydrated dermis.
Concentrated human-derived exosome preparation with a characterised growth factor and signalling protein profile for professional aesthetic protocols.
Positioned within Korea's established skin booster product ecosystem, building on the clinical framework of HA boosters, PDRN, and next-generation exosome technologies.
Applicable across multiple skin quality concerns — hydration, fine lines, overall complexion, and surface quality — within a single booster formulation.
The skin booster category has evolved from hyaluronic acid (HA) formulations to include PDRN, growth factors, and now exosome-based preparations. The following comparison reflects general category positioning — not head-to-head clinical trial data.
| Feature | HA Skin Booster | PDRN Booster | Exosome Skin Booster |
|---|---|---|---|
| Primary mechanism | Humectant / hydration | Polynucleotide support | Cellular signalling |
| Active payload | Hyaluronic acid | DNA fragments | Exosomes, growth factors, miRNA |
| Hydration support | ✓ Established | Partial | ✓ Supported |
| Skin quality breadth | Hydration-focused | Moderate | Multi-parameter |
| Evidence maturity | Established | Moderate | Emerging / preliminary |
Table reflects general category context only. Not based on controlled head-to-head clinical trials. Consult product literature and peer-reviewed research for evidence assessment.
Professional clinic environment with trained aesthetic practitioner. Not for home or consumer use. Sterile technique and appropriate training required for injection administration.
Course of sessions typically 2–6 treatments at 2–4 week intervals. Maintenance sessions may be recommended. Specific protocols vary by manufacturer guidelines and individual clinical assessment.
Frequently combined with microneedling, laser, RF devices, and other skin quality modalities. Treatment order and timing guidance available in manufacturer clinical literature.
Professional exosome products require specific storage conditions — typically 2–8°C refrigeration, protected from light, with defined shelf life. Full cold-chain requirements in product documentation.
Premium human-derived exosome for skin hydration, texture, radiance, and elasticity support in clinical protocols.
Human-derived exosome for visible skin rejuvenation, pore appearance, and firmness. Part of the ASCE+ professional range.
Advanced combination of PDRN polynucleotide technology with human-derived exosomes for comprehensive skin restoration.
A skin booster is a professional aesthetic injectable — delivered into the dermis — designed to improve overall skin quality, hydration, and appearance rather than add volume or alter facial contours. Traditional skin boosters use hyaluronic acid (HA) as the primary active. The Exosome Skin Booster replaces or supplements the HA payload with human-derived exosomes — extracellular vesicles carrying growth factors, signalling proteins, and nucleic acids associated with cellular communication and skin quality support.
Protocol specifics — including number of vials, injection technique, and session frequency — vary by product variant, treatment area, and individual clinical assessment. Manufacturer protocol documentation and professional training materials provide the recommended approach. Please contact us for full technical specifications and clinical guidance sheets.
Human-derived exosome skin boosters are generally formulated for broad clinical applicability across skin types. However, individual suitability — based on skin condition, sensitivity, medical history, and contraindications — must be assessed by the treating practitioner prior to use. Refer to the manufacturer's contraindication and precaution documentation.
The periorbital area is a technically sensitive zone for any injectable procedure. While exosome skin boosters are used by some practitioners in periorbital protocols, this requires specialist training and experience. Always follow manufacturer protocol recommendations for anatomical area guidance and ensure practitioner competence before treating sensitive facial zones.
Exosome products are biological preparations requiring careful cold-chain management. Typical storage requirements are 2–8°C refrigeration, away from light and heat. Shelf life and cold-chain specifications are provided on product packaging and in the technical data sheet available to verified professional buyers.
Professional supply to verified clinics and wholesale partners. Request our full product catalogue, technical data sheets, and clinical protocol guides.